CYTRX Aktie

2,40 EUR 26,5156%

Zu Ihrem Onlinebroker

kaufen verkaufen

CYTRX Aktienkurs : 21.05. ( 15 Min. verzögert)
2,40 € Letzter Kurs	26,52% Veränderung	1,90 € Vortag	2,40 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
2,40 - 2,40 Tag	4,73 - 1,30 52 Wochen	0 Tag	100 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

CYTRX Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

01:07

The Week's Big Movers

CytRx Corp. rose 15 percent to $3.45. The West LA biotech's stock rose in advance of an important oncology medical meeting, during which the company planned to present findings on one of its expe…
21.05.

Three Small Caps to Ride the Bounce With: CYTR, CIGX, ROSG

... better positioned to ride that rebound wave than others though, such as Star Scientific, Inc. (NASDAQ:CIGX), Rosetta Genomics Ltd. (NASDAQ:ROSG), and CytRx Corporation (NASDAQ:CYTR). If you're looking to make the most of any bounce ...

21.05.

M&A Activity and Growing Rate of FDA Approvals Contributing Factors to Biotech ...

The Paragon Report examines investing opportunities in the Biotech Industry and provides equity research on Keryx Biopharmaceuticals (NASDAQ:KERX) and CytRx Corporation (NASDAQ:CYTR) . "In 2011, the US FDA approved 30 new drugs, compared to 21 in 2010.
16.05.

CytRx Announces Reverse Stock Split

LOS ANGELES--(EON: Enhanced Online News)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company specializing in oncology, today announced a reverse split of its common stock at a...
15.05.

CytRx Announces Reverse Stock Split

LOS ANGELES, May 15, 2012 (BUSINESS WIRE) -- CytRx Corporation (NASDAQ:CYTR) , a biopharmaceutical company specializing in oncology, today announced a reverse split of its common stock at a...